We are very proud to announce that our firm advised our longstanding client Pharmathen, a leading European complex drug delivery and formulation developer, and its shareholder, Partners Group, in connection with the acquisition of CBL Patras S.A., a leading vertically integrated and FDA-approved peptide manufacturer and supplier in Europe. This milestone transaction will allow Pharmathen to strengthen its position in the global peptide therapeutics market.

The acquisition of CBL by Pharmathen marks the conclusion of yet another seminal transaction for our Corporate and M&A practice group this year.

Our team was led by Anna Manda, assisted by our Senior Associate Marina Chronaki and our Associates Aris – Nikolaos Papadopoulos and Matina Xirogianni.

Our team also included:
For corporate, commercial law and other matters: Tina Sofianou, Apostolos Latsonas, Maria-Christina Raptopoulou and Katerina Basta
For employment law: Angeliki Tsatsi
For real estate: Christina Zevla
For litigation: AIKATERINI TOUMPANOU and Konstantinos G. Bairaktaris
For GDPR issues: Dimitra Karampela and Panagiotis Kontizas

More information: https://www.pharmathen.com/sites/default/files/2023-11/Pharmathen-acquires-CBL%20Patras-Press-Release-EN.pdf